![Breakthroughs that change patients’ lives]({"type":"image" , "src" : "/sda/112393/JournalAd-TACD-Pfizer-Leaderboard.jpg"})
https://orcid.org/0000-0003-0821-4559
References
- Piepoli MF, Hoes AF, Agewall S, et al.; ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381.
- Rauch B, Davos CH, Doherty P, et al.; ‘Cardiac Rehabilitation Section’, European Association of Preventive Cardiology (EAPC), in cooperation with the Institute of Medical Biometry and Informatics (IMBI), Department of Medical Biometry, University of Heidelberg, and the Cochrane Metabolic and Endocrine Disorders Group, Institute of General Practice, Heinrich-Heine University, Düsseldorf, Germany. The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: a systematic review and meta-analysis of randomized and non-randomized studies – The Cardiac Rehabilitation Outcome Study (CROS). Eur J Prev Cardiol. 2016;23(18):1914–1939.
- Takura T, Ebata-Kogure N, Goto Y, et al. Cost-effectiveness of cardiac rehabilitation in patients with coronary artery disease: a meta-analysis. Cardiol Res Pract. 2019;2019:1–11.
- Long L, Mordi IR, Bridges C, et al. Exercise-based cardiac rehabilitation for adults with heart failure. Cochrane Database Syst Rev. 2019;1(1):CD003331.
- Ambrosetti M, Abreu A, Corrà U, et al. Secondary prevention through comprehensive cardiovascular rehabilitation: from knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2020:2047487320913379. DOI:10.1177/2047487320913379.
- Fell J, Dale V, Doherty P. Does the timing of cardiac rehabilitation impact fitness outcomes? An observational analysis. Open Heart. 2016;3(1):e000369.
- Marzolini S, Blanchard C, Alter DA, et al. Delays in referral and enrolment are associated with mitigated benefits of cardiac rehabilitation after coronary artery bypass surgery. Circ Cardiovasc Qual Outcomes. 2015;8(6):608–620.
- Scherrenberg M, Frederix I, De Sutter J, et al. Use of cardiac telerehabilitation during COVID-19 pandemic in Belgium. Acta Cardiol. 2020 Jun 30:1–4. DOI: 10.1080/00015385.2020.1786625.
- Scherrenberg M, Wilhelm M, Hansen D, et al. The future is now: a call for action for cardiac telerehabilitation in the COVID-19 pandemic from the secondary prevention and rehabilitation section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2020:2047487320939671. DOI:10.1177/2047487320939671.
- Frederix I, Vanhees L, Dendale P, et al. A review of telerehabilitation for cardiac patients. J Telemed Telecare. 2015 ;21(1):45–53. Jan
- Anderson L, Sharp GA, Norton RJ, et al. Home-based versus centre-based cardiac rehabilitation. Cochrane Database Syst Rev. 2017;6(6):CD007130.
- Frederix I, Caiani EG, Dendale P, et al. ESC e-Cardiology Working Group Position Paper: Overcoming challenges in digital health implementation in cardiovascular medicine. Eur J Prev Cardiol. 2019; 26(11):1166–1177.
![Novo Nordisk – Driving change to defeat serious chronic diseases.]({"type":"image" , "src" : "/sda/112384/TACD_NovoNordisk.jpg"})
![Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.]({"type":"image" , "src" : "/sda/112392/Skyscraper_BristolMyersSquibb.jpg"})